MedTrace Logo

Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control

NCT02002806 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-08-16

No results posted yet for this study

Summary

This is a randomized study of surgery plus chemical nerve block versus surgery plus placebo for pain control in subjects with pancreatic cancer.

Conditions

  • Pancreas Cancer
  • Biliary Tract Cancer

Interventions

OTHER

Alcohol Injection

Celiac plexus neurolysis by alcohol injection

OTHER

Placebo Injection

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Michael G House, MD · Indiana University, Department of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02002806 on ClinicalTrials.gov